Cellectis S.A. (ALCLS.PA)

EUR 1.41

(-0.71%)

Gross Profit Summary of Cellectis S.A.

  • Cellectis S.A.'s latest annual gross profit in 2023 was 18 Thousand USD , down -99.9% from previous year.
  • Cellectis S.A.'s latest quarterly gross profit in 2024 Q2 was 9.5 Million USD , up 109.87% from previous quarter.
  • Cellectis S.A. reported a annual gross profit of 17.39 Million USD in annual gross profit 2022, down -53.82% from previous year.
  • Cellectis S.A. reported a annual gross profit of 37.67 Million USD in annual gross profit 2021, down 0.0% from previous year.
  • Cellectis S.A. reported a quarterly gross profit of 9.5 Million USD for 2024 Q2, up 109.87% from previous quarter.
  • Cellectis S.A. reported a quarterly gross profit of -26 Thousand USD for 2023 Q3, down -121.14% from previous quarter.

Annual Gross Profit Chart of Cellectis S.A. (2023 - 2007)

Historical Annual Gross Profit of Cellectis S.A. (2023 - 2007)

Year Gross Profit Gross Profit Growth
2023 18 Thousand USD -99.9%
2022 17.39 Million USD -53.82%
2021 37.67 Million USD 0.0%
2020 37.67 Million USD 891.94%
2019 3.79 Million USD -61.99%
2018 9.99 Million USD -55.72%
2017 22.56 Million USD -44.82%
2016 40.89 Million USD -21.86%
2015 52.33 Million USD 131.5%
2014 22.6 Million USD 2.91%
2013 21.96 Million USD -14.8%
2012 25.78 Million USD 47.61%
2011 17.46 Million USD -8.34%
2010 19.05 Million USD 27.11%
2009 14.99 Million USD 13.35%
2008 13.22 Million USD 404.03%
2007 2.62 Million USD 0.0%

Peer Gross Profit Comparison of Cellectis S.A.

Name Gross Profit Gross Profit Difference
ABIONYX Pharma SA 618 Thousand EUR 97.087%
ABIVAX Société Anonyme 3.91 Million EUR 99.54%
Adocia SA 1.38 Million EUR 98.7%
Aelis Farma SA 12.35 Million EUR 99.854%
Biophytis S.A. -803 Thousand EUR 102.242%
Advicenne S.A. 1.42 Million EUR 98.738%
genOway Société anonyme 20.1 Million EUR 99.91%
IntegraGen SA 5.01 Million EUR 99.641%
Medesis Pharma S.A. -2.66 Million EUR 100.675%
Neovacs S.A. 29.31 Thousand EUR 38.596%
NFL Biosciences SA -56.06 Thousand EUR 132.106%
Plant Advanced Technologies SA 2.15 Million EUR 99.164%
Quantum Genomics Société Anonyme -1.41 Million EUR 101.268%
Sensorion SA 3.78 Million EUR 99.525%
Theranexus Société Anonyme -4.63 Million EUR 100.388%
TME Pharma N.V. -127 Thousand EUR 114.173%
Valbiotis SA 2.66 Million EUR 99.325%
TheraVet SA -530.79 Thousand EUR 103.391%
Valerio Therapeutics Société anonyme 1.26 Million EUR 98.579%
DBV Technologies S.A. 4.15 Million EUR 99.567%
Genfit S.A. 28.22 Million EUR 99.936%
GeNeuro SA -293.8 Thousand EUR 106.127%
Innate Pharma S.A. -4.12 Million EUR 100.437%
Inventiva S.A. 17.5 Million EUR 99.897%
MaaT Pharma SA 1.65 Million EUR 98.912%
MedinCell S.A. 9.28 Million EUR 99.806%
Nanobiotix S.A. 36.2 Million EUR 99.95%
OSE Immunotherapeutics SA 2.22 Million EUR 99.192%
Poxel S.A. 1000.00 EUR -1700.0%
GenSight Biologics S.A. 3 Million EUR 99.4%
Transgene SA -28.4 Million EUR 100.063%
Valneva SE 52.83 Million EUR 99.966%